Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Triple-negative breast cancer (TNBC) is characterized by aggressive growth and a high propensity for recurrence and metastasis. Simultaneous overexpression of c-MET and EGFR in TNBC is associated with worse clinicopathological features and unfavorable outcomes. Although the development of new c-MET inhibitors and the emergence of 3.sup.r...
Alternative Titles
Full title
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a78d66b75c4a4c13ba43af1a16e5d520
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a78d66b75c4a4c13ba43af1a16e5d520
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-023-02866-z
